Higher welfare farm animal production is increasingly economically viable, with evidence that welfare investments deliver returns through reduced disease, medication costs, and productivity improvements.
The business case for farm animal welfare is stronger than the conventional wisdom that welfare and profitability are opposed. Prevention of lameness in dairy cows costs a fraction of the combined losses from reduced milk, treatment, early culling, and replacement. Reducing tail biting through enrichment costs less than treating the injuries and losses it causes. Healthy, low-stress animals with appropriate behaviour opportunities grow more efficiently and require fewer medications. The welfare improvement investment pays back in multiple production metrics alongside the primary welfare benefit. Markets for welfare-certified products have demonstrated consumer willingness to pay modest premiums that cover the additional production costs in many product categories. The challenge is communicating this business case convincingly to farmers who face capital constraints and risk aversion.